南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

基于脂肪酸代谢的子宫内膜样子宫内膜癌风险评分模型构建与治疗指导

Novel fatty acid metabolism risk score model for guiding treatment in endometrial endometrioid cancer

Xu Xiaoxiao, Wu Qingmei, Liu Li, Liang Zhengwei, Li Lieyang, Lu Deqin, Lv Sha

Journal:Scientific Reports

IF:4.9

DOI:10.1038/s41598-026-41912-6

PMID:

Published:2026-03-19

research field:肿瘤学癌症代谢分子生物学生物信息学精准医学

Abstract

Endometrial cancer ranks among the most prevalent tumours in women, with approximately 80–85% classified as endometrioid type. Evidence has suggested a significant link between obesity and the development of endometrial endometrioid cancer (EEC). We analysed RNA sequencing data encompassing 407 EEC samples and 35 normal endometrial tissue samples sourced from TCGA, and created a risk score model built on differentially expressed genes related to fatty acid metabolism within the tumour microenvironment (TME). Patients categorised as high-risk scores exhibited a higher prevalence of dMMR and TP53 mutations, fewer mutations in KRAS and PTEN, and worse prognostic outcomes. Further investigation indicated that the two patient subgroups showed varying sensitivities to different chemotherapeutic agents. Additionally, the composition of immune cell infiltration in the TME diverged between these subgroups. Tumour Immune Dysfunction and Exclusion analysis suggested that individuals with high-risk scores are not suited for immunotherapeutic intervention. Based on bioinformatic analyses, this research offers a novel framework for the classification and therapeutic direction of EEC.

本文使用的Yeasen产品

购物车
客服
转染试用